Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2023-06-30 00:00:00 ET · period of report 2023-06-30 · accession 0001209191-23-040269 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2023-06-30 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $46.76 | -585 | 8,985 | -6% | -$27.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-30 | S | D | 585 | $46.76 | 8,985 | D | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. |